The road to approved vaccines for respiratory syncytial virus

TJ Ruckwardt - NPJ vaccines, 2023 - nature.com
After decades of work, several interventions to prevent severe respiratory syncytial virus
(RSV) disease in high-risk infant and older adult populations have finally been approved …

Direct-acting antivirals for RSV treatment, a review

B Bonneux, E Jacoby, M Ceconi, K Stobbelaar… - Antiviral Research, 2024 - Elsevier
Respiratory syncytial virus (RSV) causes respiratory disease and complications in infants,
the elderly and the immunocompromised. While three vaccines and two prophylactic …

[HTML][HTML] Genetic diversity and its impact on disease severity in respiratory syncytial virus subtype-A and-B bronchiolitis before and after pandemic restrictions in Rome

A Pierangeli, R Nenna, M Fracella, C Scagnolari… - Journal of Infection, 2023 - Elsevier
Objectives To scrutinize whether the high circulation of respiratory syncytial virus (RSV)
observed in 2021–2022 and 2022–2023 was due to viral diversity, we characterized RSV-A …

[HTML][HTML] Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0–5 years in the USA in 2022: a multicentre retrospective cohort …

L Wang, PB Davis, N Berger, DC Kaelber… - Family medicine and …, 2023 - ncbi.nlm.nih.gov
Objective To investigate whether COVID-19 infection was associated with increased risk for
incident respiratory syncytial virus (RSV) infections and associated diseases among young …

Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria

JU Oguzie, BA Petros, PE Oluniyi, SB Mehta… - Nature …, 2023 - nature.com
Effective infectious disease surveillance in high-risk regions is critical for clinical care and
pandemic preemption; however, few clinical diagnostics are available for the wide range of …

Standardized phylogenetic classification of human respiratory syncytial virus below the subgroup level

S Goya, C Ruis, RA Neher, A Meijer… - Emerging Infectious …, 2024 - pmc.ncbi.nlm.nih.gov
A globally implemented unified phylogenetic classification for human respiratory syncytial
virus (HRSV) below the subgroup level remains elusive. We formulated global consensus of …

Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID‐19 pandemic

M Redlberger‐Fritz, DN Springer… - Journal of Medical …, 2023 - Wiley Online Library
In 2022, Austria experienced a severe respiratory syncytial virus (RSV) epidemic with an
earlier‐than‐usual start (Weeks 35/2021–45/2022) and increased numbers of pediatric …

Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic …

W Cai, S Köndgen, K Tolksdorf, R Dürrwald… - …, 2024 - eurosurveillance.org
Background Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic
affected respiratory syncytial virus (RSV) circulation worldwide. Aim To describe, for children …

Respiratory syncytial virus infection in the modern era

M Ludlow - Current opinion in infectious diseases, 2023 - journals.lww.com
Respiratory syncytial virus infection in the modern era : Current Opinion in Infectious
Diseases Respiratory syncytial virus infection in the modern era : Current Opinion in …

Clinical, genomic, and immunological characterization of RSV surge in Sydney, Australia, 2022

GJ Walker, CSP Foster, A Sevendal… - …, 2024 - publications.aap.org
OBJECTIVES The 2022 seasonal respiratory syncytial virus (RSV) epidemic in Sydney,
Australia saw an unprecedented number of RSV detections. We aimed to characterize …